Docetaxel.

Article Details

Citation
Copy to clipboard

Authors unspecified

Docetaxel.

.

PubMed ID
31644206 [ View in PubMed
]
Abstract

Docetaxel is an antineoplastic agent that has a unique mechanism of action as an inhibitor of cellular mitosis and that currently plays a central role in the therapy of many solid tumors including breast and lung cancer. Docetaxel therapy is frequently associated with serum enzyme elevations which are usually transient and mild, but more importantly has been linked to rapid onset, severe hypersensitivity reactions that can be associated with acute hepatic necrosis, liver failure and death.

DrugBank Data that Cites this Article

Drugs